.

Hannah L. Graetz

Portrait of Hannah L. Graetz

Hannah represents health care providers and institutions against medical malpractice liability claims. Grounding her approach in client-centered lawyering, Hannah works closely with her clients to deliver clear communication, practical guidance, and results that genuinely reflect their goals.

Hannah earned her undergraduate degree from the University of Pittsburgh, where she majored in Economics and double-minored in History and Africana Studies. She received her J.D. from the University of Baltimore School of Law. During law school, Hannah was an intern with the Honorable Abbe F. Fletman of the Philadelphia County Court of Common Pleas. She also advocated in the Circuit Court for Baltimore City as a certified student-attorney through the law school’s Bronfein Family Law Clinic, and served as a member of the National Trial Team.

Outside of the office, Hannah volunteers for the American Bar Association Judicial Intern Opportunity program on their alumni committee, conducting interviews for potential candidates. Along with her dog Indy, she also participates at the University of Scranton’s K-9s on Campus hosted by the Center for Service & Social Justice and the NEPA Youth Shelter.

    • University of Baltimore School of Law (J.D., cum laude, 2025)
    • University of Pittsburgh (B.A., magna cum laude, 2021)
    • Maryland, 2025
    • Pennsylvania, 2025
    • American Bar Association, Litigation Section
    • Judicial Intern Opportunity Program, Alumni Committee
    • Maryland State Bar Association (2025)

Thought Leadership

The Quarterly Dose

The Impact of Berk v. Choy on Malpractice Lawsuits in Federal Court

February 25, 2026

On January 20th, 2026, in Berk v. Choy, 607 U.S.    (2026), the U.S. Supreme Court unanimously ruled that state law requirements for expert affidavits of merit in medical malpractice cases do not apply in federal court. The Court concluded that the plaintiff only needs to provide a “short and plain statement of the claim” when filing a malpractice lawsuit, effectively removing the affidavit of merit requirement. By removing this safeguard, the Court has opened the door for plaintiffs to file medical malpractice claims without having an expert review their allegations. The affidavit of merit exists to ensure that a malpractice claim has authoritative medical and legal support. Because litigation demands substantial time, energy, and emotional investment from both plaintiffs and defendants, ensuring that defendants are not subjected to unfounded claims by requiring a qualified medical expert to review the facts and determine whether a breach of the standard of care is likely an important check against allegations rooted in speculation rather than evidence. In the opinion from Choy, the majority identified Federal Rule of Civil Procedure 8 as the federal rule in conflict with Delaware’s affidavit requirement. The issue under review was whether a malpractice lawsuit may be dismissed for lack of an affidavit of merit. The majority concluded that Rule 8 sets a ceiling on what information a plaintiff is required to provide at the outset of litigation. The Court interpreted this standard to be a “short and plain statement of the claim,” finding that Delaware’s evidentiary requirement does not apply in federal court. Alternatively, Justice Jackson’s concurrence expressed a grounded view of the litigation process. She emphasized the key question of what is required to bring a medical malpractice action in federal court. Justice Jackson explained that the affidavit here is a “matter outside the pleadings,” highlighting that it cannot be required as a condition of filing under Rule 3 of the Federal Rules of Civil Procedure or considered at dismissal under Rule 21(d) of the Federal Rules. Concluding, the majority’s reliance on Rule 8 is unwarranted because it only governs what a pleading itself must contain, not what must accompany it. If the purpose of an affidavit of merit is to filter out meritless claims early, then eliminating this safeguard will not only strain our justice system, but also place a profound burden on healthcare providers. They may now face additional professional, personal, and emotional harm from claims that lack any expert foundation for merit. While it is essential that injured people have access to the courts, it is equally as important that people are not forced to defend themselves against unmeritorious claims. The Court’s ruling will have a significant impact on malpractice litigation. Federal courts may now see an increase of malpractice filings that lack early expert review. This will have a domino effect, potentially increasing discovery burdens and clogging dockets with matters not supported by expert review. This decision signals a shift toward more permissive filing standards, and we will continue to monitor the practical consequences of this new procedural landscape.

Firm Highlights

Thought Leadership

Appellate Division Affirms Dismissal of Legal Malpractice Counterclaim Against Martin Law Firm

In Martin v. Loury, 2026 N.J. Super. Unpub. LEXIS 1617 (App. Div. July 15, 2026), Martin Law Firm represented Kirk Loury in an employment matter Mr. Loury filed against his former employer, Concord Equity Group Advisors LLC (“Concord”). The allegations included, among other things, that Loury was not fairly compensated for his employment with Concord. After a bench trial finding in Loury’s favor, the Appellate Division remanded this matter in February 2016 for a second trial. During the second trial, Concord CEO, Lee Argush, testified to lower compensation estimate than first trial. On remand, the second trial judge awarded Mr. Loury the same damages as the first judge, finding Mr. Argush not credible. After the findings during the second trial, Martin Law Firm filed an action against Mr. Loury to recover legal fees and costs of representing Mr. Loury in a second bench trial and Mr. Loury filed a counterclaim against Martin Law Firm for legal malpractice, alleging he should have received an even higher award in the second bench trial. In this allegation, Mr. Loury, through his expert, claimed that Martin Law Firm should have recalled Mr. Loury to the stand to rebut Mr. Argush’s testimony to allege an alternative theory of damages. Mr. Loury’s expert admitted that the second judge already rejected Mr. Argush's theory and accepted Loury's damages theory. The trial court barred Mr. Loury’s expert and dismissed Loury's counterclaim with prejudice before convening the collection trial, and the jury ruled in Martin Law Firm’s favor. Mr. Loury appealed the trial court's pretrial rulings barring his liability expert from testifying in support of his legal malpractice counterclaim, denying his motion for summary judgment on that counterclaim, and denying his motion to amend his counterclaim by adding attorney Joseph A. Martin as a codefendant. In affirming the trial court’s decision, the Appellate Division held that the trial court properly excluded Loury’s expert testimony in the counterclaim against Martin Law Firm because the expert could not explain how calling Loury as a rebuttal witness would have increased damages when the second judge already rejected Mr. Argush's testimony and accepted Loury's damages theory, making the expert’s causation opinion speculative. The Appellate Division also held that the trial court properly denied Mr. Loury's summary judgment motion on his malpractice counterclaim because reasonable minds could differ on whether Mr. Martin's alleged failures would have changed the second judge's damages award, given the judge already found Mr. Argush not credible, creating genuine factual disputes precluding summary judgment. Also, the Appellate Division held that the trial court properly denied Loury's May 2023 motion to add Joseph Martin individually because the statute of limitations expired in February 2022, six years after the 2016 appellate remand when Mr. Loury incurred new legal costs, and relation back did not apply because Mr. Loury knew Mr. Martin's identity throughout and strategically chose to sue only Martin Law Firm in his 2019 counterclaim.